Why LEMAITRE VASCULAR INC (NASDAQ:LMAT) qualifies as a quality stock.

Quality investors are looking for the best of the best. Companies which are growing steadily and consistently, but are also in excellent financial condition. We will have a look here to see if LEMAITRE VASCULAR INC (NASDAQ:LMAT) is suited for quality investing. Investors should of course do their own research, but we spotted LEMAITRE VASCULAR INC showing up in our Caviar Cruise quality screen, so it may be worth spending some more time on it.

What matters for quality investors.

• LMAT has demonstrated significant revenue growth over the past 5 years, with a 13.41% increase. This underscores the company's ability to adapt to market dynamics and capitalize on growth opportunities.
• LMAT exhibits a strong ROIC excluding cash and goodwill, indicating efficient capital utilization and profitable operations. The 33.54% reflects the company's ability to generate returns on invested capital and underscores its commitment to delivering value to shareholders.
• LMAT maintains a healthy Debt/Free Cash Flow Ratio of 4.51, indicating a strong financial position and prudent debt management. This ratio suggests the company has sufficient free cash flow to cover its debt obligations and highlights its ability to generate cash from operations.
• LMAT demonstrates consistent Profit Quality over the past 5 years, with a strong 110.0%. This indicates the company's ability to generate sustainable and reliable profits, showcasing its long-term profitability and financial stability.
• The 5-year EBIT growth of LMAT has been remarkable, with 19.77% increase. This demonstrates the company's ability to improve its operational efficiency and indicates its competitiveness within the market.
• LMAT demonstrates a remarkable trend where its EBIT 5-year growth exceeds its Revenue 5-year growth. This indicates the company's ability to enhance its profitability through improved cost control and operational efficiency.

A complete fundamental analysis of LMAT

ChartMill assigns a proprietary Fundamental Rating to each stock. The score is computed daily by evaluating various fundamental indicators and properties. The score ranges from 0 to 10.

Overall LMAT gets a fundamental rating of 7 out of 10. We evaluated LMAT against 191 industry peers in the Health Care Equipment & Supplies industry. LMAT gets an excellent profitability rating and is at the same time showing great financial health properties. LMAT has a decent growth rate and is not valued too expensively. These ratings could make LMAT a good candidate for quality investing.

Our latest full fundamental report of LMAT contains the most current fundamental analsysis.

More ideas for quality investing can be found on ChartMill in our Caviar Cruise screen.

Keep in mind

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.